Posted on 01/26/2025 11:22:26 AM PST by Twotone
Modified Citrus Pectin has been studied now for more than 30 years, and there are some 50 published reports in the medical literature. While the most powerful evidence involves biochemically relapsed prostate cancer, it shows promise as a suppressor of metastases in a multitude of cancers including:
Prostate cancer4
Breast cancer38
Colon cancer25
Melanoma4
Ovarian cancer4
Lung cancer4
Nasopharyngeal cancer4
Leukemias4
Glioblastomas4
Today I report the case of a 70-year-old farmer with Stage 4 colon cancer with liver metastases who became cancer-free following an MCP-based protocol.
Andy Aubin was a robustly healthy farmer who had constructed his dream home in Sedona, Arizona to enjoy a life with his wife and family. Things went smoothly for nearly ten years.
Then his father contracted Prostate Cancer and developed paralysis following surgery for the disease. Feeling an obligation to help, Andy traveled to Northern California to care for him until his death. In quick succession, his mother also passed. Another tragedy struck with the untimely death of his oldest son hit by a car while riding his bicycle.
Following this, his wife contracted Pancreatic Cancer and passed away.
Andy developed his own Prostate Cancer coupled with Parkinsonism. Despite this he continued to operate his Chicken Ranch, selling eggs to the Santa Rosa locals. Andy remarried a woman who had also lost her spouse to cancer.
Cancer continued to plague him as he was soon diagnosed with Stage 4 Colon Cancer with metastases to his liver. This was about the time he was introduced to Dr. Isaac Eliaz, a Santa Rosa Integrative Physician.
As in the story of Job, Andy’s tragedies multiplied, first with his mobile home burning down, and second with his colon rupturing.
Following a partial colectomy and placement of a colostomy bag, Andy was discharged to his son’s home. Dr. Eliaz began by addressing his multiple medical conditions taking care not to worsen the Parkinsonism while treating his cancers.
However, his allopathic physicians returned him back to the hospital for elective surgery in removing the liver metastases. This was followed by two sessions of chemotherapy which were poorly tolerated. This led to worsening of his Parkinsonism, with increased stiffness and difficulty walking.
At that point, Andy decided against any further chemotherapy and pursued Dr. Eliaz’s integrative program. This included diagnostic testing revealing heavy metal toxicities with high levels of lead and mercury.
Andy underwent removal of mercury fillings. He used MCP for metal detoxification. Modified citrus pectin [MCP] is a natural chelating agent. The MCP also functioned as an anti-cancer supplement as studies have revealed it to suppress metastases through inhibiting Galectin-3.
Here is a summary of the research: Modified citrus pectin (MCP) has demonstrated several anti-cancer properties:
Inhibition of metastasis: MCP reduces cancer metastasis by interfering with cell-cell interactions, particularly by competing with galectin-3 binding12.
Tumor growth reduction: Oral administration of MCP has been shown to decrease the growth of breast and colon tumors in animal models13.
Anti-angiogenic effects: MCP inhibits the formation of new blood vessels that support tumor growth13.
Induction of apoptosis: MCP can induce programmed cell death in cancer cells4.
Enhanced chemotherapy response: MCP may increase the apoptotic response of tumor cells to chemotherapy by inhibiting galectin-3's anti-apoptotic function2.
Broad-spectrum activity: MCP has shown anti-cancer effects against various types of cancer, including breast, colon, prostate, and liver cancers134.
In addition, Dr. Eliaz began herbal treatments to reduce inflammation. Andy consistently improved and within three years became colon cancer free while his prostate cancer remained under excellent control.
His Parkinsonism noticeably improved.
Andy underwent colostomy reversal surgery which completed his recovery. And he returned to full ranch duties and enjoyed the remainder of his life passing away from non-cancer causes some 12 years following his colon cancer diagnosis.
His story is chronicled in the documentary, “The Incurables.”
However, modified citrus pectin, in inhibiting Galectin-3, is not just beneficial in treating various cancers. It works as a toxic metal chelating agent and has shown remarkable effectiveness in treating lead toxicity in children.
I find it helpful in dealing with the rising levels of environmental aluminum, especially the airborne nanoparticles.
It is not merely effective in slowing the rate of doubling of PSA. But it is also effective at preventing and treating dementia. Daily use can improve cognitive function within 6 weeks.
And it has shown activity against Spike Protein Disease. I was intrigued to find it also shows efficacy in treating Lyme Disease:
Where does one but this MCP? Don’t tell me, I can’t. Thanks Big Pharma.
Very interesting. Thank you for posting.
Fen-Ben seems to be the drug of choice right now for Stage 4 cancer. A friend of mine is on it, so we’ll see how it goes.
Best wishes and prayers for your friend; please keep us apprised from time-to-time on their progress.
bfl
“Best wishes and prayers for your friend; please keep us apprised from time-to-time on their progress.”
Thanks very much! Just started 2 weeks ago...should know in a few months.
What about MCP and cancer?
Some people with cancer may take MCP as a supplement because they’ve heard it reduces tumor growth.
However, the charity Cancer Research UK highlights that professionals consider MCP an alternative therapy, and there is not enough evidence from scientific research to suggest that it treats cancer.
The National Cancer Institute (NCI)Trusted Source summarizes research suggesting that MCP may help to protect against lung, prostate, colon, and other cancers. It may do this by triggering cell death and affecting the spread of tumor cells.
Research into MCP and leukemia also suggests that MCP may stimulate the immune system, triggering natural killer cells in leukemia cell systems.
Despite these potential effects, the Food and Drug Administration (FDA) has not approved MCP as a treatment for any medical condition, including cancer. Further research is necessary to understand the extent of its benefits as a remedy for various cancers.
https://www.healthline.com/health/8-questions-about-mcp#cancer-treatment
Per Web MD
Pectin for cancer
Pectin may have a potential role in cancer care. In a small study of men with prostate cancer for whom standard treatment had failed, MCP appeared to slow the cancer growth. A longer-term study showed that MCP had a positive effect on prostate-specific antigen (PSA) levels for men with a particular type of prostate cancer. In breast and prostate cancer, MCP may help stop the production of proteins that allow cancer cells to move and invade other tissues. Another form of pectin has been shown to block key pathways involved in pancreatic cancer cell growth.
https://www.webmd.com/vitamins-and-supplements/pectin-uses-and-risks
Prostate Cancer:
In-vitro and animal studies suggest that MCP may slow the growth of certain cancer cells, including human prostate cancer cells (Yan, Integr Cancer Ther 2010; Glinsky, Carbohydr Res 2009; Nangia-Makker, J Natl Cancer Inst 2002). However, there have been only two clinical studies on the effects of MCP in men with prostate cancer and neither study included a control group or placebo, making the results questionable.
One small clinical trial of 10 men with prostate cancer who were given MCP after traditional treatments failed (radical prostatectomy, radiation or cryosurgery) found that a daily dose of 14.4 g (6 capsules containing 800 mg Pecta-Sol® taken three times per day) for 12 months significantly slowed the rate at which prostate antigen (PSA) levels increased in the blood (Guess, Prostate Cancer Prostatic Dis 2003). (There is a higher risk of death when PSA levels rise rapidly, such as doubling in just three months. A slower rise, such as a doubling over one to 10 years, is associated with local rather than systemic recurrence (Tollefson, Mayo Clin Proc 2007)).
A second clinical study in Germany found that among 29 men and women with various advanced solid cancerous tumors (including 10 men with prostate cancer tumors) who took 5 grams of MCP powder (mixed with water and juice three times per day) for two to four months, an overall clinical response associated with a stabilization and/or improvement in measures of quality of life, such as fatigue, pain, and appetite was reported. The study also included individuals with breast, colorectal, liver, pancreatic and cervical cancer (Azemar, Clin Med Insights Oncol 2007).
Breast Cancer:
Similarly, evidence that MCP may be beneficial for slowing breast cancer growth is very preliminary. The study above that found MCP improved certain measures of quality of life in men and women with various types of cancer included five patients with advanced solid breast cancer tumors, although results were reported for the whole group, not by specific types of cancer, and the study did not a control group or placebo, which is necessary to show that a treatment is effective (Azemar, Clin Med Insights Oncol 2007). The only other evidence appears to be a study in mice injected with human breast cancer cells found that MCP given orally slowed breast tumor growth (Nangia-Makker, J Natl Cancer Inst 2002).
The Susan G. Komen foundation for breast cancer notes “Modified citrus pectin is still considered an experimental therapy for cancer and should be used as an adjuvant to standard cancer therapy under medical supervision.”
The bottom line:
Preliminary evidence suggests modified citrus pectin may slow the growth of cancerous cells or improve quality of life measures in individuals with prostate or breast cancer, but use of MCP is still considered experimental. Larger, placebo-controlled studies are needed. It is general well-tolerated, although itching, upset stomach, gas, cramping and diarrhea have been reported. Look for supplements containing Pectasol® and PectaSol-C®, which have been used in clinical studies.
Cancer, ivermectin thalidomide and vit D / Dr. John Campbell Video
Repurposing Ivermectin to augment chemotherapy’s efficacy in osteosarcoma
There are some embedded links that didn’t post through if you go to this web page. There are many beneficial drugs out there that are not used as they don’t benefit Big Pharma. Even if it doesn’t end cancer completely, the ability to suppress cancer cells would be important for those who’ve been through the normal treatments & are trying to prevent a recurrence.
MCP has other properties that I’m interested, particularly chelation therapy.
Sounds like what Ivm and Fenbendazole treatments are doing.
Good for Andy!!
Thx for posting.
Very comprehensive journal article on it.
Pectin: A Bioactive Food Polysaccharide with Cancer Preventive Potential (Molecules. 2022 Oct 31;27(21):7405)
https://pmc.ncbi.nlm.nih.gov/articles/PMC9657392/
Concluding Remarks and Future Directions
The cytotoxic effects of pectin provide it with anti-cancer properties, which have been shown to inhibit tumor growth and proliferation. MCPs inhibit almost all cancer cells via inhibition of the MAPK signal pathway. The high monogalacturonic acid content of PectaSol-C may make it easier to absorb and disperse than other PectaSols. LRP3-S1 inhibited the MAPK and FAK/AKT/GSK-3 signaling pathways in pancreatic cancer cell lines BxPC-3, PANC-1, and AsPC-1.
Colon cancer cells invade the liver through galectins, carbohydrate-based recognition proteins. The uPA receptor (uPAR) controls cell adhesion, migration, and invasion, and MCP inhibits the urokinase-type plasminogen activator (uPA) production in breast and prostate cancer cells. CP boosted LPS/Toll-like receptor 4 (TLR-4) signaling while decreasing AP-1 and NF-B signaling and activating macrophages in addition. In another study, CP and apple pectin (AP) suppressed MDA-MB-231, MCF-7, and T47D breast cancer cells.
This inhibition occurred in the S and G1 or G2/M stages of the cell cycle, the researchers found. By preventing the production of B-cell lymphoma-extra-large (Bcl-xL), cyclin B, and the epithelial-mesenchymal transition, LCP reduced the growth and spread of intestinal cancer cells in gastric cancer (EMT). Another research looked into how MCP may inhibit the formation of ordered emboli and lessen the growth of tumors. The capacity of tumor cells to attach to the endothelium and basement membrane of blood arteries is required for liver metastasis. Therefore, galectins may be required in different phases of metastasis. Finally, MCPs reduced in vitro cell survival independent of androgen dependence.
CASP3 activation and MAPK inhibition may restrict cell growth and enhance apoptosis in the presence of MCPs. Therefore, further clinical and basic research is required to establish the role of specific dietary carbohydrate molecules as chemopreventive or therapeutic agents.
I try to be very objective when I research something, while keeping an open mind.
I have had colon cancer(lost 22 inches) and lung cancer(lost half of left lung) in the past 15 years so the topic is of interest to me. Thank you for posting on it.
Amazing results are also being seen for both of those cancers, with Ivm and FenBen ... Dr William Makis has published several case studies, on each.
Continued good health, to you!
Bump
I’ve seen that Dr. John Campbells videos on YT. He seems smart.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.